Cofounding Team
W. Taylor Cottle, Ph.D. CEO & Cofounder
W. Taylor Cottle, Ph.D. CEO & Cofounder
W. Taylor Cottle, Ph.D. CEO & Cofounder
Dr. Cottle is a biotech consultant and serial founder. He received a doctoral degree from Johns Hopkins University School of Medicine. With a strong background in business and funding strategies, he manages our team and drives the development and commercialization of SHARP technologies.
Momcilo Gavrilov, Ph.D. CSO & Cofounder
W. Taylor Cottle, Ph.D. CEO & Cofounder
W. Taylor Cottle, Ph.D. CEO & Cofounder
Dr. Gavrilov is an entrepreneurial scientist who co-invented SHARP technology during his postdoctoral appointment at Johns Hopkins University School of Medicine. His primary focus is on R&D for commercial products, and he is committed to driving innovation for future customer solutions and products.
Advisory Team
Fahad Rashid, Ph.D. Biochemistry Consultant
Dr. Rashid is an seasoned researcher serving as a postdoctoral fellow at the Johns Hopkins School of Medicine. With his extensive experience in protein and nucleic acid biochemistry, Dr. Rashid is supporting R&D and manufacturing at SHARP.
How SHARP Diagnostics started?
SHARP technology, a groundbreaking innovation in nucleic acid amplification, emerged from the laboratory of Prof. Taekjip Ha at Johns Hopkins University School of Medicine in Baltimore, MD. Momčilo, the leading postdoctoral fellow on the project, played a pivotal role in implementing an engineered helicase for nucleic acid amplification. Meanwhile, Taylor focused on utilizing engineered helicase for genome editing applications. Leveraging their extensive research experience, the SHARP Diagnostics team was formed and demonstrated the commercial potential at the 2022 HopStart business competition held at Johns Hopkins University, where their business plan was honored with the prestigious Garrick Ahn Award. After the competition, SHARP Diagnostics LLC was established with the mission to push the boundaries of molecular diagnostic technologies, drive advancements in next-generation point-of-care and home tests, and make molecular diagnostics cost effective and widely available.
Featured